SCHEMBL7721906

SCHEMBL7721906

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)Nc1nc2cc(Cl)ccc2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.39
ANO1 Q5XXA6 1/20 0.39
PTGES O14684 5/20 0.39
ABL1 P00519 3/20 0.39
BCR P11274 3/20 0.39
EGFR P00533 2/20 0.38
BTK Q06187 2/20 0.38
NPY5R Q15761 1/20 0.38
HCRTR2 O43614 2/20 0.37
HCRTR1 O43613 1/20 0.37
FFAR2 O15552 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
CASR P41180 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7728192 0.82 POLB (0.47) ABL1BCRCYP1A2POLBCYP3A4
SCHEMBL7727754 0.79 POLB (0.44) ABL1BCRCYP1A2POLBCYP3A4
SCHEMBL7721904 0.77 ANO1 (0.41) USP30ANO1PTGESABL1BCR
SCHEMBL13257793 0.76 ALDH1A1 (0.53) USP30PTGESNPY5RHCRTR2HCRTR1
SCHEMBL16238597 0.76 ALDH1A1 (0.53) USP30PTGESNPY5RHCRTR2HCRTR1
SCHEMBL7729236 0.76 HDAC4 (0.41) ABL1BCRCYP1A2POLBCYP3A4
SCHEMBL7725709 0.75 NPC1 (0.43) ABL1BCRCYP1A2POLBCYP3A4
SCHEMBL7731725 0.74 HDAC8 (0.44) ABL1BCRCYP1A2POLBCYP3A4
SCHEMBL7734065 0.73 UCHL1 (0.49) USP30ALDH1A1
SCHEMBL7731479 0.73 HDAC8 (0.44) NPY5RCYP1A2POLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed